TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis.

Grazia Arpino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.